๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

MGMT promoter methylation and immunoexpression in aggressive pituitary adenomas and carcinomas

โœ Scribed by Fateme Salehi; Bernd W. Scheithauer; Johann M. Kros; Queenie Lau; Michael Fealey; Dana Erickson; Kalman Kovacs; Eva Horvath; Ricardo V. Lloyd

Publisher
Springer US
Year
2011
Tongue
English
Weight
201 KB
Volume
104
Category
Article
ISSN
0167-594X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Infrequent promoter methylation of the M
Infrequent promoter methylation of the MGMT gene in liver metastases from uveal melanoma
โœ Verena Voelter; Annie-Claire Diserens; Alexandre Moulin; Georg Nagel; Pu Yan; Eu ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 180 KB

## Abstract Uveal melanoma is associated with a high mortality rate once metastases occur, with over >90% of metastatic patients dying within less than 1 year from metastases to the liver. The intraarterial hepatic (iah) administration of the alkylating agent fotemustine holds some promise with res

A specific CpG methylation pattern of th
A specific CpG methylation pattern of the MGMT promoter region associated with reduced MGMT expression in primary colorectal cancers
โœ Klaus K.-F. Herfarth; Thomas P. Brent; Rebecca P. Danam; Joanna S. Remack; Ira J ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 122 KB ๐Ÿ‘ 2 views

The enzyme O 6 -methylguanine-DNA methyltransferase (MGMT) protects cells from the cytotoxic and mutagenic effects of alkylating agents. Approximately 20% of tumor cell lines lack MGMT activity and are highly sensitive to alkylating agents. In established cancer cell lines, MGMT expression appears t